{
    "organizations": [],
    "uuid": "b2e5f6973ab4a0db3e6ecb723fe88c2cf5b38e53",
    "author": "cnbc.com",
    "url": "https://www.cnbc.com/2018/02/22/the-associated-press-sangamo-reports-4q-loss.html",
    "ord_in_thread": 0,
    "title": "Sangamo reports 4Q loss",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "RICHMOND, Calif. (AP) _ Sangamo Therapeutics Inc. (SGMO) on Thursday reported a loss of $13.1 million in its fourth quarter.\nThe Richmond, California-based company said it had a loss of 15 cents per share.\nThe results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 18 cents per share.\nThe drug developer posted revenue of $13.1 million in the period, also beating Street forecasts. Three analysts surveyed by Zacks expected $11.3 million.\nFor the year, the company reported that its loss narrowed to $54.6 million, or 70 cents per share. Revenue was reported as $36.6 million.\nSangamo shares have increased 55 percent since the beginning of the year. The stock has risen sixfold in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on SGMO at https://www.zacks.com/ap/SGMO",
    "published": "2018-02-22T17:19:00.000+02:00",
    "crawled": "2018-02-23T01:05:37.011+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "richmond",
        "ap",
        "sangamo",
        "therapeutic",
        "sgmo",
        "thursday",
        "reported",
        "loss",
        "million",
        "fourth",
        "quarter",
        "richmond",
        "company",
        "said",
        "loss",
        "cent",
        "per",
        "share",
        "result",
        "beat",
        "wall",
        "street",
        "expectation",
        "average",
        "estimate",
        "five",
        "analyst",
        "surveyed",
        "zacks",
        "investment",
        "research",
        "loss",
        "cent",
        "per",
        "share",
        "drug",
        "developer",
        "posted",
        "revenue",
        "million",
        "period",
        "also",
        "beating",
        "street",
        "forecast",
        "three",
        "analyst",
        "surveyed",
        "zacks",
        "expected",
        "million",
        "year",
        "company",
        "reported",
        "loss",
        "narrowed",
        "million",
        "cent",
        "per",
        "share",
        "revenue",
        "reported",
        "million",
        "sangamo",
        "share",
        "increased",
        "percent",
        "since",
        "beginning",
        "year",
        "stock",
        "risen",
        "sixfold",
        "last",
        "month",
        "story",
        "generated",
        "automated",
        "insight",
        "http",
        "using",
        "data",
        "zacks",
        "investment",
        "research",
        "access",
        "zacks",
        "stock",
        "report",
        "sgmo",
        "http"
    ]
}